RECURSION PHARMACEUTICALS, INC. Quarterly Long-term Debt and Lease Obligation in USD from Q4 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
Recursion Pharmaceuticals, Inc. quarterly Long-term Debt and Lease Obligation history and growth rate from Q4 2023 to Q3 2024.
  • Recursion Pharmaceuticals, Inc. Long-term Debt and Lease Obligation for the quarter ending September 30, 2024 was $20.5M.
Long-term Debt and Lease Obligation, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $20.5M Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $22.9M Jun 30, 2024 10-Q 2024-08-08
Q4 2023 $1.1M Dec 31, 2023 10-Q 2024-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.